Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yaolin Wang
Institution:
InventisBio Co., Ltd. (China)
Observed institution:
InventisBio Co., Ltd. (China)
ORCID:
0000-0003-2662-3858
Observed ORCID:
0000-0003-2662-3858
OpenAlex ID:
A5015389259
D‐1553: A novel KRASG12C inhibitor with potent and selective cellular and in vivo antitumor activity
2023
·
Zhe Shi
, Jifang Weng
, et al.
·
Cancer Science
·
43
PDF
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
2025
·
Dan-Yun Ruan
, Hao-Xiang Wu
, et al.
·
Signal Transduction and Targeted Therapy
·
31
PDF
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
2025
·
Noboru Yamamoto
, Dong Yan
, et al.
·
British Journal of Cancer
·
7
Show more works
View as search
Works count:
3
Citation count:
81
H-index:
3
I10-index:
2
Year
Topic
Type
